Stroke and deep venous thrombosis complicating intravenous immunoglobulin infusions.

Stroke and deep venous thrombosis complicating intravenous immunoglobulin infusions. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Stroke and deep venous thrombosis complicating intravenous immunoglobulin infusions. Abstract Text:

Stroke and deep venous thrombosis complicating intravenous immunoglobulin infusions. Publishing Authors By Initials

For similar cardiovascular diseases: vascular diseases: embolism and thrombosis: thrombosis: venous thrombosis research abstracts see: cardiovascular diseases: vascular diseases: embolism and thrombosis: thrombosis: venous thrombosis research

PUBMED ID PMID:

MEDLINE DATE:

Stroke and deep venous thrombosis complicating intravenous immunoglobulin infusions. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Archives of dermatology

VOLUME: 139

Page Numbers: 991-3

Journal Abbreviation: Arch Dermatol

ISSN: 0003-987X

DAY: 17

MONTH: Aug

YEAR: 2003

Stroke and deep venous thrombosis complicating intravenous immunoglobulin infusions. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 372433

Stroke and deep venous thrombosis complicating intravenous immunoglobulin infusions. Keywords Mesh Terms:

KEYWORDS: Venous Thrombosis

MESH TERMS: chemically induced

Chemical & Substance for Abstract: Stroke and deep venous thrombosis complicating intravenous immunoglobulin infusions. Information

Substance Name: Immunoglobulins, Intravenous

Registry Number: 0

Grant and Affiliation Information for Stroke and deep venous thrombosis complicating intravenous immunoglobulin infusions.

AFFILIATION: University of Pennsylvania Medical Center, Philadelphia, PA 19104-4283, USA.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Arch Dermatol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Stroke and deep venous thrombosis complicating intravenous immunoglobulin infusions Related Publications

• Activation of autoimmunity following use of immunostimulatory herbal supplements.
• CONTINUING EDUCATION: Is It Valid?
• Combination antimalarials in the treatment of cutaneous dermatomyositis: a retrospective study.
• Cutaneous lupus: insights into pathogenesis and disease classification.
• Dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris.
• Dermatologic therapeutics: thalidomide. A practical guide.
• Dermatology vignette. Pseudoporphyria caused by NSAIDs.
• Development of outcome measures for autoimmune dermatoses.
• Failure of physiologic doses of pure UVA or UVB to induce lesions in photosensitive cutaneous lupus erythematosus: implications for phototesting.
• Lizard ecology: evidence of competition.
• Number, characteristics, and classification of patients with dermatomyositis seen by dermatology and rheumatology departments at a large tertiary medical center.
• Numerous erythematous truncal plaques. Multiple basal cell carcinomas associated with arsenic ingestion.
• Pathophysiology of cutaneous lupus erythematosus.
• RISK MANAGEMENT FOR CHIROPRACTORS AND OSTEOPATHS: Neck Manipulation & Vertebrobasilar Stroke.
• Regeneration of sulfur-fouled bimetallic Pd-based catalysts.
• Reliability of fMRI during a Continuous Motor Task: Assessment of Analysis Techniques.
• Risk Management for Chiropractors and Osteopaths. Informed consent: A Common Law Requirement.
• Stroke and deep venous thrombosis complicating intravenous immunoglobulin infusions.
• The cutaneous lupus erythematosus disease activity and severity index: Expansion for rheumatology and dermatology.
• The cutaneous lupus erythematosus disease area and severity index: a responsive instrument to measure activity and damage in patients with cutaneous lupus erythematosus.
• Treatment of bullous pemphigoid with topical corticosteroids: review of a randomized controlled trial.
• Treatment of pemphigus vulgaris with brief, high-dose intravenous glucocorticoids.
• Ulcerating skin lesions and arthritis after a crab bite.
• What is new in the treatment of steroid-induced osteoporosis?
• What is new in the treatment of steroid-induced osteoporosis?
• [Effect of malachite green on metabolism, especially on the enzymes of the respiratory chain in rats and their relation to the problem of abnormalities and carcinogenesis.]
• [Incidence of hereditary disorders caused by prolonged malachite green poisoning in rats; a contribution to chemogenesis.]
• [Methods of experimental research on cancer and its significance in practical medicine.]
• [The effect of malachite green on the growth of Walker rat carcinoma and Ehrlich mouse ascites tumor.]
• [The history of medicine. Richard Werth (1850-1918)]